NASDAQ$CDXS

Codexis Inc · Q4 2019 earnings

Q4 2019 earnings · · Investor relations

Briefing

Codexis reported a 16% increase in Q4 revenues, reaching $18.7 million, and closed 2019 with a 13% total revenue growth.

Codexis reported strong fourth-quarter revenues of $18.7 million, a 16% increase over the prior-year quarter. The Performance Enzymes segment led the way in 2019 with a 24% increase in revenues. The company's outlook for 2020 is for another year of double-digit revenue growth, up 14% to 20% over 2019.

  • Total revenues for the fourth quarter of 2019 were $18.7 million, up 16% from $16.1 million for the fourth quarter of 2018.
  • Product revenue was $4.9 million, compared with $7.3 million for the fourth quarter of 2018, with the decrease due to timing in the demand for various enzymes.
  • Research and development (R&D) revenue for the fourth quarter of 2019 was $13.8 million, up 57% from $8.8 million for the prior-year period.
  • The net loss for the fourth quarter of 2019 was $0.6 million, or $0.01 per share, compared with a net loss for the fourth quarter of 2018 of $0.5 million, or $0.01 per share.

Headline financials

Total Revenue

$18.7M

Previous: $16.1M+16.1%
EPS (adj)

-$0.01

Previous: $0.03-133.3%
Capital Expenditures

$415K

No prior period
Free Cash Flow

-$4.08M

No prior period
Net Income

-$635K

No prior period
Operating Income

-$946K

No prior period
Gross Profit

$15.2M

No prior period
Cash & Equivalents

$90.5M

No prior period
Total Assets

$149M

No prior period
Stock-Based Comp

$1.16M

No prior period

Revenue & EPS history

Codexis · Revenue · Quarterly

$18.7M

Q4 2019+16.1%vs Q4 2018
Beat estimate in 5 of 16 quarters(31%)
ActualEstimate

Forward guidance

Codexis is introducing financial guidance for 2020, expecting total revenues to be $78 million to $82 million and product revenues to be $25 million to $27 million, with gross margin on product revenue expected to be 43% to 47%.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2019

Historical avgQ4 2019

-0.4%

Avg return

Earnings day

-0.0%

Avg return

5 days after

+1.2%

Avg return

30 days after

48%

31 / 64 earnings

Positive

+33.9%

Q4 2025

Best reaction

-24.5%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.0%-4.5%-4.5%
Q4 2025+33.9%+15.7%+76.4%
Q3 2025-4.3%-8.9%-26.7%
Q1 2025+1.2%-0.8%-9.7%
Q4 2024-22.6%-30.5%-28.5%
Q3 2024+9.0%+19.0%+42.7%
Q2 2024-7.3%-7.3%-9.3%
Q1 2024+26.0%+13.5%+8.7%
Q4 2023+12.0%+1.4%-15.9%
Q3 2023+16.3%+4.8%+48.8%
Q2 2023-10.0%-28.7%-43.9%
Q1 2023-8.1%-24.4%-35.7%
Q4 2022-14.0%-12.0%-29.5%
Q3 2022+10.3%+4.9%-1.4%
Q2 2022+12.5%+0.0%-13.4%
Q1 2022-9.2%-17.3%-20.9%
Q4 2021+15.9%+13.5%+13.1%
Q3 2021+18.8%+18.7%-3.7%
Q2 2021+17.2%+18.6%+29.2%
Q1 2021-5.0%-9.9%-0.4%
Q4 2020-3.4%-1.3%-9.6%
Q3 2020+2.3%+9.1%+23.9%
Q2 2020+6.8%+1.9%-4.9%
Q1 2020+2.3%-2.9%+2.2%
Q4 2019-10.2%-12.2%-20.6%
Q3 2019+10.1%+11.4%+10.0%
Q2 2019-14.4%-14.9%-15.9%
Q1 2019-5.7%-3.3%-11.9%
Q4 2018-1.6%-5.3%-7.7%
Q3 2018-7.2%-9.0%+25.3%
Q2 2018+4.0%+10.4%+32.0%
Q1 2018+9.1%+14.2%+25.9%
Q4 2017+3.3%+18.6%-3.3%
Q3 2017-3.1%-8.5%+6.2%
Q2 2017+5.9%+5.0%+10.9%
Q1 2017+1.1%+0.0%-2.2%
Q4 2016+6.0%+8.3%+7.1%
Q3 2016+2.2%+10.8%+8.6%
Q2 2016+2.8%+0.0%-4.2%
Q1 2016+2.5%
Q4 2015-5.9%
Q3 2015+2.9%
Q2 2015-3.1%
Q1 2015-7.4%
Q4 2014+5.4%
Q3 2014-8.1%
Q2 2014+7.1%
Q1 2014+1.3%
Q4 2013+3.1%
Q3 2013-16.6%
Q2 2013-12.5%
Q1 2013+0.5%
Q4 2012-8.5%
Q3 2012-17.4%
Q2 2012-24.5%
Q1 2012-2.4%
Q4 2011-8.7%
Q3 2011+0.4%
Q2 2011-9.3%
Q1 2011-5.6%
Q4 2010-1.5%
Q3 2010-8.1%
Q2 2010-5.5%
Q1 2010-0.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro